Security key
449778109
IO Biotech, Inc. - Common Stock, par value $0.001 per share (IOBTQ)
CUSIP: 449778109
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 26,183,049
- Total 13F value
- $30,634,167
- Share change
- -1,158,861
- SEC-reported price per share
- $1.17
- Number of holders
- 19
- Value change
- -$1,443,320
- Number of buys
- 6
- Number of sells
- 5
- Shares outstanding
- 79,751,533
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
19
Top holders
10
IOBTQ full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
IO Biotech, Inc. SEC filings
IO Biotech, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 449778109
Recent filing periods:
Ownership snapshot
Top reported holders of IOBTQ - IO Biotech, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital, LLC
Disclosed value leader
Vivo Capital, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 7.7%
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital, LLC leads the comparable SEC ownership view at 7.7%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital, LLC
7.7%
Novo Holdings A/S
6.4%
Samsara BioCapital, LLC
4.6%
PFM Health Sciences, LP
2.9%
MORGAN STANLEY
2.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
Company
|
7.7%
|
$10,680,049
6,173,439 shares
|
— | 31 Mar 2024 |
| Novo Holdings A/S |
13F
Company
|
6.4%
|
$8,802,686
5,088,258 shares
|
— | 31 Mar 2024 |
| Samsara BioCapital, LLC |
13F
Company
|
4.6%
|
$6,297,226
3,640,015 shares
|
— | 31 Mar 2024 |
| PFM Health Sciences, LP |
13F
Company
|
2.9%
|
$4,050,115
2,341,107 shares
|
— | 31 Mar 2024 |
| MORGAN STANLEY |
13F
Company
|
2.8%
|
$3,801,215
2,197,234 shares
|
— | 31 Mar 2024 |
| MARSHALL WACE, LLP |
13F
Company
|
2.6%
|
$3,684,208
2,105,262 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
19
Shares
26,183,049
Rows available
19
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
17
Q2 2024 holders
19
Holder diff
2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend